pdf

Wall to Present Webinar on ANDAs and Hatch-Waxman Act

April 4, 2017

O’Melveny associate Carolyn Wall will speak as part of The Knowledge Group’s “ANDAs and the Hatch-Waxman Act” webcast on April 4, 2017. The presentation will cover cases, trends, and developments to watch for in 2017 in light of the continued rise of Abbreviated New Drug Application (ANDA) filings.

Specifically, Wall will address:

  • Jurisdiction in light of Acorda and TC Heartland
  • 2016 FDA revisions to ANDA regulations
  • Exclusivity after Benicar
  • Interaction between district court litigation and post-grant proceedings (and effects of the Trump administration)

Based in O’Melveny’s New York office, Wall is an intellectual property litigator who concentrates her practice on ANDA/Hatch-Waxman and other patent litigation.